0001209191-16-153908.txt : 20161207
0001209191-16-153908.hdr.sgml : 20161207
20161207163546
ACCESSION NUMBER: 0001209191-16-153908
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161206
FILED AS OF DATE: 20161207
DATE AS OF CHANGE: 20161207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc.
CENTRAL INDEX KEY: 0001567514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364742850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 212-923-3344
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Oneida Resources Corp.
DATE OF NAME CHANGE: 20130122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALAFI MOSHE
CENTRAL INDEX KEY: 0001008890
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36274
FILM NUMBER: 162039415
MAIL ADDRESS:
STREET 1: 1311 ORLEANS DRIVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-12-06
0
0001567514
Intra-Cellular Therapies, Inc.
ITCI
0001008890
ALAFI MOSHE
C/O ALAFI CAPITAL COMPANY, LLC
8 ADMIRAL DRIVE, SUITE 324
EMERYVILLE
CA
94608
0
0
1
0
Common Stock
2016-12-06
4
P
0
44174
16.3319
A
3674379
I
Held by Alafi Capital Company, LLC
Common Stock
2016-12-07
4
P
0
20826
16.1355
A
3695205
I
Held by Alafi Capital Company, LLC
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.28 to $16.50 per share, inclusive.
Mr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Mr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.91 to $16.37 per share, inclusive.
/s/ Lawrence J. Hineline, Attorney-in-fact
2016-12-07